BuzzSparks.org

Calithera Biosciences


Calithera is a development stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- cancer...

Founded in 2010
Employees: 33
Homepage:
Total money raised: $89M

94080 343 Oyster Point
Suite 200

South San Francisco
USA CA
Updated on Oct 30, 2013
Calithera Biosciences at CrunchBase
Susan M. Molineaux President & CEO
Mark K. Bennett Senior Vice President
Jean George Board of Directors
Past
Larry Lasky Led the Firm's Participation

October, 2013

Calithera Biosciences raised $35M in a Series D round from Adage Capital Management, Morgenthaler Ventures, Advanced Technology Ventures, and Delphi Ventures

Calithera Biosciences Completes $35M Series D Financing    finsmes.com

December, 2012

Calithera Biosciences raised $2M in a Series C round from Advanced Technology Ventures, Delphi Ventures, and Morgenthaler Ventures

May, 2012

Calithera Biosciences raised $8M in a Series B round

SEC    sec.gov

April, 2012

Calithera Biosciences raised $4M in unattributed round from Advanced Technology Ventures, Delphi Ventures, Morgenthaler Ventures, and US Venture Partners

July, 2010

Calithera Biosciences raised $40M in a Series A round from Morgenthaler Ventures, US Venture Partners, Advanced Technology Ventures, Delphi Ventures, and Mission Bay Capital

ALITHERA BIOSCIENCES CLOSES $40 MILLION IN SERIES A FINANCING    calithera.com

June, 2010

Calithera Biosciences was founded on June, 2010